{
    "organizations": [],
    "uuid": "06ba3dab9d13f780abbc8feeeaa0f132e026c22a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-avexis-inc-q1-loss-per-share-620/brief-avexis-inc-q1-loss-per-share-6-20-idUSASC09ZN7",
    "ord_in_thread": 0,
    "title": "Avexis Inc Q1 Loss Per Share $6.20",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 3 (Reuters) - AveXis Inc:\n* AVEXIS REPORTS FIRST QUARTER 2018 FINANCIAL AND OPERATING RESULTS\n* Q1 LOSS PER SHARE $6.20 * Q1 EARNINGS PER SHARE VIEW $-3.32 â€” THOMSON REUTERS I/B/E/S\n* AVXS-101 PRE-BLA MEETING WITH FDA IS SCHEDULED TO BE HELD IN JUNE 2018\n* AS OF MARCH 31, 2017, AVEXIS HAD $586.8 MILLION IN CASH AND CASH EQUIVALENTS Source text for Eikon:\nOur ",
    "published": "2018-05-04T04:22:00.000+03:00",
    "crawled": "2018-05-04T16:54:24.034+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "avexis",
        "inc",
        "avexis",
        "report",
        "first",
        "quarter",
        "financial",
        "operating",
        "result",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "meeting",
        "fda",
        "scheduled",
        "held",
        "june",
        "march",
        "avexis",
        "million",
        "cash",
        "cash",
        "equivalent",
        "source",
        "text",
        "eikon"
    ]
}